Scholarly Index
Juan P. Rodrigo
Hospital Universitario Central de Asturias; 16,338 total citations; 498 total publications; best world rank #60
Hospital Universitario Central de Asturias
16,338Total citations
498Total publications
67H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Head and Neck Cancer Studies | Lifetime | 84 | ES 1 | 99.47 |
| Head and Neck Surgical Oncology | Lifetime | 95 | ES 1 | 99.36 |
| Ear and Head Tumors | Lifetime | 60 | ES 2 | 99.15 |
| Cancer Diagnosis and Treatment | Lifetime | 258 | ES 2 | 98.50 |
| Cancer-related gene regulation | Lifetime | 295 | ES 6 | 98.31 |
| Salivary Gland Tumors Diagnosis and Treatment | Lifetime | 396 | ES 8 | 97.47 |
| S100 Proteins and Annexins | Lifetime | 434 | ES 6 | 95.93 |
| Reconstructive Surgery and Microvascular Techniques | Lifetime | 976 | ES 7 | 95.44 |
| Head and Neck Cancer Studies | 2021-2025 | 91 | ES 4 | 98.09 |
| Head and Neck Surgical Oncology | 2021-2025 | 228 | ES 7 | 92.97 |
| Inflammatory Biomarkers in Disease Prognosis | 2021-2025 | 373 | ES 4 | 83.78 |
| Cancer-related gene regulation | 2021-2025 | 627 | ES 2 | 82.04 |
| Ear and Head Tumors | 2021-2025 | 296 | ES 1 | 81.66 |
| Thyroid and Parathyroid Surgery | 2021-2025 | 769 | ES 8 | 72.11 |
| Hippo pathway signaling and YAP/TAZ | 2021-2025 | 914 | ES 10 | 54.15 |
| NF-κB Signaling Pathways | 2021-2025 | 778 | ES 15 | 35.58 |